0001567619-21-004471.txt : 20210218
0001567619-21-004471.hdr.sgml : 20210218
20210218192658
ACCESSION NUMBER: 0001567619-21-004471
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210216
FILED AS OF DATE: 20210218
DATE AS OF CHANGE: 20210218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Claflin Bruce L.
CENTRAL INDEX KEY: 0001403694
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 21651427
MAIL ADDRESS:
STREET 1: 7035 RIDGE ROAD
CITY: HANOVER
STATE: MD
ZIP: 21076
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
doc1.xml
FORM 4
X0306
4
2021-02-16
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001403694
Claflin Bruce L.
C/O IDEXX LABORATORIES, INC.
ONE IDEXX DRIVE
WESTBROOK
ME
04092
1
0
0
0
Common Stock
2021-02-16
4
M
0
5902
85
A
6206
D
Common Stock
2021-02-16
4
M
0
1125
160.28
A
7331
D
Common Stock
2021-02-16
4
S
0
6745
536.8856
D
586
D
Common Stock
2021-02-16
4
S
0
586
537.1931
D
0
D
Non-Qualified Stock Option (right-to-buy)
85
2021-02-16
4
M
0
5902
D
2026-05-03
Common Stock
5902
0
D
Non-Qualified Stock Option (right-to-buy)
160.28
2021-02-16
4
M
0
1125
D
2027-05-02
Common Stock
1125
1921
D
Represents the weighted average price of the shares sold ranging from a low of $536.13 to a high of $537.125 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $537.15 to a high of $537.23 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the date of the 2017 annual meeting of shareholders.
Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 3, 2018.
Not applicable.
/s/ Lily J. Lu, Attorney-in-Fact for Bruce L. Claflin
2021-02-18